Scientists hunt for brain tumor clues in blood and spinal fluid
NCT ID NCT06610682
Summary
This study aims to find out if tiny pieces of tumor DNA (ctDNA) found in blood and spinal fluid can be used to monitor how a brain tumor responds to an experimental drug called plixorafenib. It will enroll 15 adults with a specific BRAF-V600E mutated brain tumor that has returned after prior treatment. The main goal is to see if these liquid biopsies are a feasible way to track the disease, while also gathering early data on the drug's effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAF V600E MUTATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Johns Hopkins
RECRUITINGBaltimore, Maryland, 21231, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.